Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: Single low-dose INC280-loaded theranostic nanoparticles achieve multirooted delivery for MET-targeted primary and liver metastatic NSCLC

Fig. 1

Schematic illustrations of synthesis of INC280-PFCE NPs and corresponding theranostic strategy and characterization. A Scheme of the synthesis of the INC280-PFCE NPs and theranostic strategy. B Size distribution of INC280-PFCE NPs determined by DLS. C The average zeta potential values of PFCE NPs and INC280-PFCE NPs. D INC280-PFCE NPs were characterized by TEM. Scale bar is 100 nm for small view and 1000 nm for large view. E After storage at 4, 25 and 37 °C, size stability tests of INC280-PFCE NPs over 6 consecutive weeks. F 19F-MR images of INC280-PFCE NPs with increasing concentrations of 19F (CF). 1–5: 2.59, 5.19, 10.37, 20.74, 41.48 mg/mL, respectively. G 19F-NMR of INC280-PFCE NPs

Back to article page